A detailed history of Envestnet Asset Management Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 36,192 shares of WVE stock, worth $217,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,192
Previous 32,331 11.94%
Holding current value
$217,513
Previous $399,000 26.82%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025

BUY
$8.08 - $13.51 $31,196 - $52,162
3,861 Added 11.94%
36,192 $292,000
Q4 2024

Feb 12, 2025

BUY
$8.0 - $16.44 $101,792 - $209,182
12,724 Added 64.9%
32,331 $399,000
Q3 2024

Nov 06, 2024

BUY
$5.12 - $9.01 $20,659 - $36,355
4,035 Added 25.91%
19,607 $160,000
Q2 2024

Aug 08, 2024

BUY
$4.38 - $6.48 $68,205 - $100,906
15,572 New
15,572 $77,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $522M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.